Tezspire™ (tezepelumab injection) now available in Canada for severe asthma

/CNW/ - Today, AstraZeneca and Amgen announced the Canadian availability of Tezspire™ (tezepelumab injection), indicated for the add-on maintenance treatment...

Related Keywords

Canada ,Japan ,Canadians ,Canadian ,Lymphopoietin Isoforms ,Anne Ellis ,Mary Anne Cedrone ,Daniel Martinez ,Astrazeneca Canada Inc ,Amgen ,Canadian Society Of Allergy ,Professor Of Medicine At Queen University ,World Allergy Organization ,Astrazeneca ,Allergy Immunology Department ,Global Asthma Network ,Health Canada ,A Canadian Thoracic Society ,Airways Of Human Asthmatics In Vivo ,Immunology Department ,Canadian Society ,Kiersten Combs ,Executive Medical Director ,New England Journal ,Rare Disease ,Amgen Canada ,Canadian Product ,Stromal Lymphopoietin Isoforms ,Inflammatory Disorders ,Human Asthmatics In Vivo ,Potential Biomarker ,Severe Refractory ,Moderate To Severe Uncontrolled ,Global Asthma ,Global Asthma Report ,Asthma Facts ,Canadian Thoracic Society ,Critical Care ,Possible Explanation ,Explor Res Hypothesis ,Allergy Asthma ,Illness Among Patients ,Severe Asthma ,Managed Care ,Care Respir ,Allergy Organization ,Zeneca Canada ,Astrazeneca Canada ,